참고문헌
- Albain KS, Crowley JJ, LeBlanc M, Livingston RB (1990). Determinants of improved outcome in small-cell lung cancer: an analysis of the 2,580-patient Southwest Oncology Group data base. J Clin Oncol, 8, 1563-74.
- Barone BB, Yeh HC, Snyder CF, et al (2004). Long-term allcause mortality in cancer patients with preexisting diabetes mellitus: a systematic review and meta-analysis. JAMA, 17, 2754-64.
- Boyle P, Ferlay J (2005). Cancer incidence and mortality in Europe, 2004. Ann Oncol, 16, 481-8. https://doi.org/10.1093/annonc/mdi098
- Bremnes RM, Sundstrom S, Aasebo U, et al (2003). Norweigian Lung Cancer Study Group. The value of prognostic factors in small cell lung cancer: results from a randomised multicenter study with minimum 5 year follow-up. Lung Cancer, 39, 303-13. https://doi.org/10.1016/S0169-5002(02)00508-1
- Cerny T, Blair V, Anderson H, Bramwell V, Thatcher N (1987). Pretreatment prognostic factors and scoring system in 407 small-cell lung cancer patients. Int J Cancer,151, 46-9.
- Fry WA, Menck HR, Winchester DP (1996). The National Cancer Data Base report on lung cancer. Cancer, 77, 1947-55. https://doi.org/10.1002/(SICI)1097-0142(19960501)77:9<1947::AID-CNCR27>3.0.CO;2-Z
- Foster NR, Mandrekar SJ, Schild SE, et al (2009). Prognostic Factors Differ by Tumor Stage for Small Cell Lung Cancer. Cancer, 15, 2721-31.
- Hansen O, Sørensen P, Hansen KH (2010). The occurrence of hyponatremia in SCLC and the influence on prognosis: a retrospective study of 453 patients treated in a single institution in a 10-year period. Lung Cancer, 68, 111-4. https://doi.org/10.1016/j.lungcan.2009.05.015
- Huang YC, Lin JK, Chen WS, et al (2011). Diabetes mellitus negatively impacts survival of patients with colon cancer, particularly in stage II disease. J Cancer Res Clin Oncol, 137, 211-20. https://doi.org/10.1007/s00432-010-0879-7
- Jackman DM, Johnson BE (2005). Small-cell lung cancer. Lancet, 366, 1385-96. https://doi.org/10.1016/S0140-6736(05)67569-1
- Krishnan S, Rana V, Janjan NA, et al (2006). Prognostic factors in patients with unresectable locally advanced pancreatic adenocarcinoma treated with chemoradiation. Cancer, 107, 2589-96. https://doi.org/10.1002/cncr.22328
-
Lassen U, Osterlind K, Hansen M, et al (1995). Longterm survival in small-cell lung cancer: post-treatment characteristics in patients surviving 5 to
${\geq}$ 18 years-an analysis of 1,714 consecutive patients. J Clin Oncol, 13, 1215-20. - Mitry E, Douillard JY, Van Cutsem E, et al (2004). Predictive factors of survival in patients with advanced colorectal cancer: an individual data analysis of 602 patients included in irinotecan phase III trial. Ann Oncol, 15, 1013-7. https://doi.org/10.1093/annonc/mdh267
- Quoix E, Purohit A, Faller-Beau M, et al (2000). Comparative prognostic value of lactate dehydrogenase and neuronspecific enolase in small-cell lung cancer patients treated with platinum-based chemotherapy. Lung Cancer, 30, 127-34. https://doi.org/10.1016/S0169-5002(00)00131-8
- Park SM, Lim MK, Shin SA, Yun YH (2006). Impact of prediagnosis smoking, alcohol, obesity, and insulin resistance on survival in male cancer patients: National Health Insurance Corporation Study. J Clin Oncol, 24, 5017-24. https://doi.org/10.1200/JCO.2006.07.0243
- Peairs KS, Barone BB, Snyder CF, et al (2011). Diabetes mellitus and breast cancer outcomes: a systematic review and metaanalysis. J Clin Oncol, 29, 40-6. https://doi.org/10.1200/JCO.2009.27.3011
- Pelayo Alvarez M, Gallego Rubio O, Bonfill Cosp X, Agra Varela Y (2009). Chemotherapy versus best supportive care for extensive small cell lung cancer. Cochrane Database Syst Rev: CD001990.
- Sculier JP, Chansky K, Crowley JJ, Van Meerbeeck J, Goldstraw P (2008). The impact of additional prognostic factors on survival and their relationship with the anatomical extent of disease expressed by the 6th edition of the TNM Classification of Malignant Tumors and the proposals for the 7th edition. J Thorac Oncol, 3, 457-66. https://doi.org/10.1097/JTO.0b013e31816de2b8
- Serke M, Schonfeld N (2007). Diagnosis and staging of lung cancer. Dtsch Med Wochenschr, 132, 1165-9. https://doi.org/10.1055/s-2007-979393
- Tammemagi CM, Neslund-Dudas C, Simoff M, Kvale P (2003). Impact of comorbidity on lung cancer survival. Int J Cancer, 103, 792-802. https://doi.org/10.1002/ijc.10882
- Tas F, Aydiner A, Demir C, Topuz E (2001). Serum lactate dehydrogenase levels at presentation predict outcome of patients with limited-stage small-cell lung cancer. Am J Clin Oncol, 24, 376-8. https://doi.org/10.1097/00000421-200108000-00013
- Van de Poll-Franse LV, Houterman S, Janssen-Heijnen ML, et al (2007). Less aggressive treatment and worse overall survival in cancer patients with diabetes: a large population based analysis. Int J Cancer, 120, 1986-92. https://doi.org/10.1002/ijc.22532
- Varlotto J, Medford-Davis LN, Recht A, et al (2011). Confirmation of the role of diabetes in the local recurrence of surgically resected non-small cell lung cancer. Lung Cancer, 75, 381-90.
- Win T, Sharples L, Groves AM, et al (2008). Predicting survival in potentially curable lung cancer patients. Lung, 186, 97-102. https://doi.org/10.1007/s00408-007-9067-1
- Yip D, Harper PG (2000). Predictive and prognostic factors in small cell lung cancer: current status. Lung Cancer, 28, 173-85. https://doi.org/10.1016/S0169-5002(00)00105-7
- Zelen M (1973). Keynote address on biostatistics and data retrieval. Cancer Chemother Rep, 4, 31-42.
피인용 문헌
- Diabetes - Increased Risk for Cancers through Chromosomal Aberrations? vol.15, pp.11, 2014, https://doi.org/10.7314/APJCP.2014.15.11.4571
- Prognostic significance of diabetes mellitus in locally advanced non-small cell lung cancer vol.15, pp.1, 2015, https://doi.org/10.1186/s12885-015-2012-4